Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered.

Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases.

Vanderbilt University researchers have come closer to solving a mystery that has puzzled scientists for more than a century: after the loss of one kidney, what causes the growth of the remaining kidney to take up the slack?

Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

Arthur Dalley, Ph.D., professor of Cell and Developmental Biology at Vanderbilt, recently received the highest education award for human anatomy education in the anatomical sciences during the 2015 Experimental Biology meeting in Boston.

A Vanderbilt physician researcher is highlighting that orthopaedic surgeons are among the highest prescribers of opioid pain medicine in the United States and calling on practitioners to exercise caution when prescribing the potentially addictive pain medicine.

Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever.